126
Views
3
CrossRef citations to date
0
Altmetric
Original Research

Tiotropium as an Add-on Treatment Option for Severe Uncontrolled Asthma in Preschool Patients

ORCID Icon, , , , , , & ORCID Icon show all
Pages 23-30 | Published online: 14 Jan 2021

References

  • Ferrante G, La Grutta S. The burden of pediatric asthma. Front Pediatr. 2018;6:186. doi:10.3389/fped.2018.00186
  • Akinbami LJ, Moorman JE, Garbe PL, Sondik EJ. Status of childhood asthma in the United States, 1980–2007. Pediatrics. 2009;123:S131–S145. doi:10.1542/peds.2008-2233C
  • Hogg JC, Pare PD, Hackett TL. The contribution of small airway obstruction to the pathogenesis of chronic obstructive pulmonary disease. Physiol Rev. 2017;97(2):529–552. doi:10.1152/physrev.00025.2015
  • Carlsen KH. What distinguishes the asthmatic amongst the infant wheezers? Pediatr Allergy Immunol. 1997;8:40–45.
  • Kurukulaaratchy RJ, Matthews S, Holgate ST, Arshad SH. Predicting persistent disease among children who wheeze during early life. Eur Respir J. 2003;22(5):767–771. doi:10.1183/09031936.03.00005903
  • Beigelman A, Bacharier LB. Management of preschool recurrent wheezing and asthma: a phenotype-based approach. Curr Opin Allergy Clin Immunol. 2017;17(2):131–138. doi:10.1097/ACI.0000000000000344
  • Global Initiative for Asthma. Global strategy for asthma management and prevention (2019 report). Available from: https://ginasthma.org/wp-content/uploads/2019/06/GINA-2019-main-report-June-2019-wms.pdf. Accessed October 29, 2019.
  • Bisgaard H, Zielen S, Garcia-Garcia ML, et al. Montelukast reduces asthma exacerbations in 2- to 5-year-old children with intermittent asthma. Am J Respir Crit Care Med. 2005;171(4):315–322. doi:10.1164/rccm.200407-894OC
  • Zielen S, Christmann M, Kloska M, et al. Predicting short term response to anti-inflammatory therapy in young children with asthma. Curr Med Res Opin. 2010;26(2):483–492. doi:10.1185/03007990903485148
  • Kaiser SV, Huynh T, Bacharier LB, et al. Preventing exacerbations in preschoolers with recurrent wheeze: a meta-analysis. Pediatrics. 2016;137(6):e20154496. doi:10.1542/peds.2015-4496
  • Loke YK, Blanco P, Thavarajah M, Wilson AM, Zhang L. Impact of inhaled corticosteroids on growth in children with asthma: systematic review and meta-analysis. PLoS One. 2015;10(7):e0133428. doi:10.1371/journal.pone.0133428
  • Hamelmann E, Bateman ED, Vogelberg C, et al. Tiotropium add-on therapy in adolescents with moderate asthma: a 1-year randomized controlled trial. J Allergy Clin Immunol. 2016;138(2):441–450.e448. doi:10.1016/j.jaci.2016.01.011
  • Paggiaro P, Halpin DM, Buhl R, et al. The effect of tiotropium in symptomatic asthma despite low- to medium-dose inhaled corticosteroids: a randomized controlled trial. J Allergy Clin Immunol Pract. 2016;4(1):104–113.e102. doi:10.1016/j.jaip.2015.08.017
  • Vogelberg C, Szefler SJ, Vrijlandt EJLE, et al. Tiotropium add-on therapy is safe and reduces seasonal worsening in paediatric asthma patients. Eur Respir J. 2019;53(6):pii: 1801824. doi:10.1183/13993003.01824-2018
  • Bickmann D, Kamin W, Sharma A, Wachtel H, Moroni-Zentgraf P, Zielen S. In vitro determination of Respimat® dose delivery in children: an evaluation based on inhalation flow profiles and mouth-throat models. J Aerosol Med Pulm Drug Deliv. 2016;29:76–85. doi:10.1089/jamp.2014.1166
  • Kamin W, Frank M, Kattenbeck S, Moroni-Zentgraf P, Wachtel H, Zielen S. A handling study to assess use of the Respimat® Soft Mist Inhaler in children under 5 years old. J Aerosol Med Pulm Drug Deliv. 2015;28(5):372–381. doi:10.1089/jamp.2014.1159
  • Vrijlandt EJLE, El Azzi G, Vandewalker M, et al. Safety and efficacy of tiotropium in children aged 1–5 years with persistent asthmatic symptoms: a randomised, double-blind, placebo-controlled trial. Lancet Respir Med. 2018;6(2):127–137. doi:10.1016/S2213-2600(18)30012-2
  • Pedersen SE, Hurd SS, Lemanske RF, et al. Global strategy for the diagnosis and management of asthma in children 5 years and younger. Pediatr Pulmonol. 2011;46(1):1–17. doi:10.1002/ppul.21321
  • Farber HJ, Silveira EA, Vicere DR, Kothari VD, Giardino AP. Oral corticosteroid prescribing for children with asthma in a Medicaid managed care program. Pediatrics. 2017;139(5):e20164146. doi:10.1542/peds.2016-4146
  • Matsumoto H, Ishihara K, Hasegawa T, Umeda B, Niimi A, Hino M. Effects of inhaled corticosteroid and short courses of oral corticosteroids on bone mineral density in asthmatic patients: a 4-year longitudinal study. Chest. 2001;120(5):1468–1473. doi:10.1378/chest.120.5.1468
  • Lemanske RF, Mauger DT, Sorkness CA, et al. Step-up therapy for children with uncontrolled asthma receiving inhaled corticosteroids. N Engl J Med. 2010;362(11):975–985. doi:10.1056/NEJMoa1001278
  • Jackson DJ, Bacharier LB, Mauger DT, et al. Quintupling inhaled glucocorticoids to prevent childhood asthma exacerbations. N Engl J Med. 2018;378(10):891–901. doi:10.1056/NEJMoa1710988
  • Chauhan BF, Chartrand C, Ni Chroinin M, Milan SJ, Ducharme FM. Addition of long-acting beta2-agonists to inhaled corticosteroids for chronic asthma in children. Cochrane Database Syst Rev. 2015;(11):CD007949. doi:10.1002/14651858.CD007949.pub2
  • Yoshihara S, Tsubaki T, Ikeda M, et al. The efficacy and safety of fluticasone/salmeterol compared to fluticasone in children younger than four years of age. Pediatr Allergy Immunol. 2019;30(2):195–203. doi:10.1111/pai.13010
  • Stallworth LE, Fick DM, Ownby DR, Waller JL. Antibiotic use in children who have asthma: results of retrospective database analysis. J Manag Care Pharm. 2005;11(8):657–662. doi:10.18553/jmcp.2005.11.8.657
  • De Boeck K, Vermeulen F, Meyts I, Hutsebaut L, Franckaert D, Proesmans M. Coprescription of antibiotics and asthma drugs in children. Pediatrics. 2011;127(6):1022–1026. doi:10.1542/peds.2009-3068
  • Baan EJ, Janssens HM, Kerckaert T, et al. Antibiotic use in children with asthma: cohort study in UK and Dutch primary care databases. BMJ Open. 2018;8(11):e022979. doi:10.1136/bmjopen-2018-022979